Evidence map›Paper›PMID 36889612›Full record

ArticleJournal of the American College of Cardiology2023

Virtual Care Team Guided Management of Patients With Heart Failure During Hospitalization.

Ankeet S Bhatt, Anubodh S Varshney, Alea Moscone, Brian L Claggett, Zi Michael Miao, Safia Chatur, Mathew S Lopes, John W Ostrominski, Maria A Pabon, Ozan Unlu and 43 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American College of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. SGLT2 Inhibitor Prescribing in Cardiovascular-Kidney-Metabolic Syndrome.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Colchicine's Role in Cardiovascular Disease Management.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

53 authors.

Ankeet S BhattDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA; Kaiser Permanente San Francisco Medical Center and Division of Research, San Francisco, California, USA.
Anubodh S VarshneyDivision of Cardiovascular Medicine, Stanford University, Palo Alto, California, USA.
Alea MosconeDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Brian L ClaggettDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
Zi Michael MiaoDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
Safia ChaturDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
Mathew S LopesDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
John W OstrominskiDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
Maria A PabonDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
Ozan UnluDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
Xiaowen WangDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
Thomas D BernierRush University Medical Center, Chicago, Illinois, USA.
Leo F BuckleyDepartment of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Bryan CookMass General Brigham Center for Drug Policy, Boston, Massachusetts, USA.
Rachael EatonDepartment of Pharmacy, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Jillian FieneDepartment of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Dareen KanaanDepartment of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Julie KellyDepartment of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Danielle M KnowlesDepartment of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Kenneth LupiDepartment of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Lina S MattaDepartment of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Liriany Y PimentelDepartment of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Megan N RhotenDepartment of Pharmacy Services, Carilion Roanoke Memorial Hospital, Roanoke, Virginia, USA.
Rhynn MalloyDepartment of Pharmacy, Children's Hospital Colorado, Denver, Colorado, USA.
Clara TingUniversity of Chicago Medical Center, Chicago, Illinois, USA.
Rosette ChhorBrigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
Joshua R GuerinBrigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
Scott L SchisselBrigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
Brenda HoaBrigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
Connie H LioBrigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
Kristina MilewskiBrigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
Michelle E EspinosaBrigham and Women's Faulkner Hospital, Mass General Brigham, Jamaica Plain, Massachusetts, USA.
Zhenzhen LiuSalem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
Ralph McHattonSalem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
Jonathan W CunninghamDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
Karola S JeringDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
John H BertotDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Gurleen KaurDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Adeel AhmadSalem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
Muhammad AkashSalem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
Farideh DavoudiSalem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
Mona Z HinrichsenSalem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
David L RabinSalem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
Patrick L GordanSalem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
David J RobertsSalem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
Daniela UrmaSalem Hospital, Mass General Brigham, Salem, Massachusetts, USA.
Erin E McElrathDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Emily D HincheyDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Niteesh K ChoudhryDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Mahan NekouiDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Scott D SolomonDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
Dale S AdlerDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Muthiah VaduganathanDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: mvaduganathan@bwh.harvard.edu.

Funding

TRAINING PROGRAM IN CARDIOVASCULAR RESEARCHT32HL007604 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MARK W FEINBERG · 1985 to 2026
$19.0M
Inflammasome Activity as a Potential Contributor to Uremic CardiomyopathyK23HL150311 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BUCKLEY, LEO FRANCIS · 2020 to 2024
$1.1M
NHLBI NIH HHS K23 HL150311NHLBI NIH HHS T32 HL007604
6 · The paper itself

Abstract

backgroundScalable and safe approaches for heart failure guideline-directed medical therapy (GDMT) optimization are needed.

objectivesThe authors assessed the safety and effectiveness of a virtual care team guided strategy on GDMT optimization in hospitalized patients with heart failure with reduced ejection fraction (HFrEF).

methodsIn a multicenter implementation trial, we allocated 252 hospital encounters in patients with left ventricular ejection fraction ≤40% to a virtual care team guided strategy (107 encounters among 83 patients) or usual care (145 encounters among 115 patients) across 3 centers in an integrated health system. In the virtual care team group, clinicians received up to 1 daily GDMT optimization suggestion from a physician-pharmacist team. The primary effectiveness outcome was in-hospital change in GDMT optimization score (+2 initiations, +1 dose up-titrations, -1 dose down-titrations, -2 discontinuations summed across classes). In-hospital safety outcomes were adjudicated by an independent clinical events committee.

resultsAmong 252 encounters, the mean age was 69 ± 14 years, 85 (34%) were women, 35 (14%) were Black, and 43 (17%) were Hispanic. The virtual care team strategy significantly improved GDMT optimization scores vs usual care (adjusted difference: +1.2; 95% CI: 0.7-1.8; P < 0.001). New initiations (44% vs 23%; absolute difference: +21%; P = 0.001) and net intensifications (44% vs 24%; absolute difference: +20%; P = 0.002) during hospitalization were higher in the virtual care team group, translating to a number needed to intervene of 5 encounters. Overall, 23 (21%) in the virtual care team group and 40 (28%) in usual care experienced 1 or more adverse events (P = 0.30). Acute kidney injury, bradycardia, hypotension, hyperkalemia, and hospital length of stay were similar between groups.

conclusionsAmong patients hospitalized with HFrEF, a virtual care team guided strategy for GDMT optimization was safe and improved GDMT across multiple hospitals in an integrated health system. Virtual teams represent a centralized and scalable approach to optimize GDMT.

Indexed as

Heart FailureAgedAged, 80 and overFemaleHospitalizationHumansMaleMiddle AgedPatient Care TeamStroke VolumeVentricular Function, Leftguideline-directed medical therapyheart failureimplementationvirtual care team

Identifiers

PMID36889612
PMCPMC10947307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.